CVE-2026-31997OpenClaw versions prior to 2026.3.1 fail to pin executable identity for non-path-like argv[0] tokens in system.run approvals, allowing post-approval executable rebind attacks.
Updated under an hour ago ()
Does this affect you?
It affects openclaw. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
OpenClaw versions prior to 2026.3.1 fail to pin executable identity for non-path-like argv[0] tokens in system.run approvals, allowing post-approval executable rebind attacks. Attackers can modify PATH resolution after approval to execute a different binary than the operator approved, enabling arbitrary command execution.
- CVSS
- 6.7 MEDIUM (v3.1, NVD)CVSS:3.1/AV:L/AC:H/PR:L/UI:R/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-367
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
openclaw openclaw openclaw:openclaw | before 2026.3.1 | NVD |
References
- https://github.com/openclaw/openclaw/security/advisories/GHSA-q399-23r3-hfx4mitigation, vendor-advisory
- https://www.vulncheck.com/advisories/openclaw-executable-rebind-via-unbound-path-token-in-system-run-approvalsthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.